A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

NCT07476118 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Brenipatide
OTHER: Placebo

Sponsor

Eli Lilly and Company